<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03867695</url>
  </required_header>
  <id_info>
    <org_study_id>6755</org_study_id>
    <nct_id>NCT03867695</nct_id>
  </id_info>
  <brief_title>SERRATHOR TRIAL : Interest of the Novel Serratus Plane Block in Post Operative Analgesia After Video-Assisted Thoracoscopic Lobectomy</brief_title>
  <acronym>SERRATHOR</acronym>
  <official_title>SERRATHOR Trial : Analgesic Effect of Serratus Plane Block After Video-Assisted Thoracoscopic Surgery Lobectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain after thoracic surgery remains a challenge for anesthetists. Although VATS for lobectomy
      is associated with fewer complications compared to thoracotomy, pain after VATS needs to be
      treated with opioids. Opioids may lead to PONV, respiratory depression, sedation and
      pruritus. As part of multimodal analgesia and opioids sparing, several local regional
      techniques has been described: paravertebral block, thoracic epidural analgesia, intercostal
      block. To date, there is no gold standard for regional anesthesia after VATS.

      Serratus plane block is a local regional technique, recently described for analgesia after
      breast surgery and ribs fracture. In our hospital center, since 2016, we used the Serratus
      plane block for patients scheduled for lobectomy VATS : a local retrospective trial showed
      that SPB was associated with a lower consumption of morphine.

      The purpose of this randomized controlled double blinded study is to evaluate the analgesic
      effect of the Serratus plane block, added to a general anesthesia on post operative pain
      control after VATS lobectomy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total intravenous morphine consumption (mg) in the PACU and department.</measure>
    <time_frame>24 hours</time_frame>
    <description>Including the dose of titration while the patient is in PACU and PCA up to 24h postoperatively.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Video Assisted Thoracoscopic Surgery</condition>
  <condition>Lobectomy</condition>
  <condition>Pain Post Operative</condition>
  <condition>Regional Anesthesia</condition>
  <arm_group>
    <arm_group_label>Serratus Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At the end of the lobectomy VATS procedure, 0,5 mL/kg of 0.375% ropivacaine will be administered.
Under ultrasonography assistance, block will be performed at the fifth rib in the midaxillary line. Local anesthetic will be injected either superficial to the serratus anterior muscle or deep underneath the muscle.
Anesthesiologists, and all the nurses and caring staff involved in this study will be blinded. Solutions of ropivacaine will be prepared identically by the central pharmacy, without any possible identification of the product.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Block - Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive a placebo injection with 0,5 mL/kg of sterile normal solution. Under ultrasonography assistance, placebo will be injected at the fifth rib in the midaxillary line, either superficial to the serratus anterior muscle or deep underneath the muscle.
Anesthesiologists, and all the nurses and caring staff involved in this study will be blinded. Solutions of sterile saline will be prepared identically by the central pharmacy, without any possible identification of the product.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>At the end of the lobectomy VATS procedure, 0,5 mL/kg of 0.375% ropivacaine will be administered.</description>
    <arm_group_label>Serratus Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sterile saline</intervention_name>
    <description>Patients will receive a placebo injection with 0,5 mL/kg of sterile normal solution</description>
    <arm_group_label>Placebo Block - Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  All patients undergoing lobectomy VATS

          -  Older &gt; 18 years

          -  Patients who meet criteria of ASA 1 to 3 class

        Exclusion criteria:

          -  Patient's refusal to participate in the study

          -  Psychiatric disorder (impossibility to collect the informed consent)

          -  Patient under juridical protection

          -  On going an other study

          -  Non balanced epilepsy

          -  3 grade auriculo-ventricular heart block without pacing

          -  Severe hepatocellular insufficiency

          -  Anti arrhythmic treatment : class III of the Vaughan William's classification

          -  Pregnant patient or/and breastfeeding

          -  History of opioid abuse

          -  Allergy to local anesthetic drug or opioids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bob HEGER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bob HEGER</last_name>
    <phone>+33 3.69.55.04.43</phone>
    <email>Bob.Heger@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gharib AJOB</last_name>
    <phone>+33 3.69.55.07.92</phone>
    <email>Gharib.ajob@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Bob HEGER</last_name>
      <phone>+33 3.69.55.04.43</phone>
      <email>Bob.Heger@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Bob HEGER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gharib AJOB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annick STEIB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul-Michel MERTES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier HELMS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fayçal EL MILOUDI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François FISCHER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile GROS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francois LEVY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Emmanuel FALCOZ</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas SANTELMO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 1, 2019</study_first_submitted>
  <study_first_submitted_qc>March 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2019</study_first_posted>
  <last_update_submitted>June 3, 2019</last_update_submitted>
  <last_update_submitted_qc>June 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Serratus plane block</keyword>
  <keyword>Analgesia after VATS</keyword>
  <keyword>Lobectomy VATS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

